BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
Authors:
Open Access
- 25 August 2023
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-11
Abstract
Checkpoint kinase 1 (CHK1), a key effector in the cellular response to DNA lesions, is a crucial component of all cell cycle checkpoints. Recent reports have revealed that CHK1 is highly expressed in numerous cancer types in the clinical settings. However, the mechanisms underlying the regulation of CHK1 expression in tumor cells remain unclear. Here, we report that CHK1 is negatively regulated by the bromodomain-containing protein 7 (BRD7). Specifically, BRD7 silencing increased CHK1 (but not CHK2) expression at both mRNA and protein levels, in a p53-independent manner in multiple tumor cell lines. Furthermore, BRD7 silencing stabilized CHK1 via reducing its ubiquitination. Mechanistically, BRD7 knockdown not only increased the levels of USP1, a deubiquitinase for CHK1, but also promoted the interaction between CHK1 and USP1, subsequently enhancing the de-ubiquitination of CHK1. USP1 knockdown abrogated BRD7 silencing-induced CHK1 induction. Biologically, the increased expression of CHK1 in tumor cells caused by BRD7 silencing significantly increased cell sensitivity to CHK1 inhibitors by enhancing tumor cell apoptosis, and this effect was reversed by the simultaneous knockdown of CHK1 or USP1. Taken together, our findings suggest that BRD7 is a potential genetic or drug target that may help to improve the efficacy of chemotherapeutic drugs targeting CHK1 in combinatorial therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81972591)
This publication has 52 references indexed in Scilit:
- Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genesNucleic Acids Research, 2011
- USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradationHuman Molecular Genetics, 2011
- Chk1 inhibits replication factory activation but allows dormant origin firing in existing factoriesJournal of Cell Biology, 2010
- Chk1 promotes replication fork progression by controlling replication initiationProceedings of the National Academy of Sciences, 2010
- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA RepairCancer Research, 2010
- Chk1 suppressed cell deathCell Division, 2010
- Novel Positive Feedback Loop between Cdk1 and Chk1 in the Nucleus during G2/M TransitionJournal of Biological Chemistry, 2009
- The F Box Protein Fbx6 Regulates Chk1 Stability and Cellular Sensitivity to Replication StressMolecular Cell, 2009
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cellsMolecular Cancer Therapeutics, 2009
- BRD7, a Novel PBAF-specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem CellsJournal of Biological Chemistry, 2008